Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Dolby Laboratories, Inc. from 28 Sep 2018 to 26 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
- Summary
-
Dolby Laboratories, Inc. quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 28 Sep 2018 to 26 Dec 2025.
- Dolby Laboratories, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 26 Dec 2025 was $65,795,000, a 294% decline year-over-year.
- Dolby Laboratories, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2025 was $215,609,000.
- Dolby Laboratories, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $240,214,000, a 227% decline from 2023.
- Dolby Laboratories, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $189,595,000.
- Source SEC data
- View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)
Dolby Laboratories, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $65,795,000 | -$99,700,000 | -294% | 27 Sep 2025 | 26 Dec 2025 | 10-Q | 29 Jan 2026 | 2026 | Q1 | |
| Q4 2024 | $33,905,000 | +$143,213,000 | 28 Sep 2024 | 27 Dec 2024 | 10-Q | 29 Jan 2026 | 2026 | Q1 | ||
| Q4 2023 | $109,308,000 | -$112,414,000 | -3619% | 30 Sep 2023 | 29 Dec 2023 | 10-Q | 30 Jan 2025 | 2025 | Q1 | |
| Q4 2022 | $3,106,000 | +$171,706,000 | 01 Oct 2022 | 30 Dec 2022 | 10-Q | 02 Feb 2024 | 2024 | Q1 | ||
| Q4 2021 | $168,600,000 | -$208,046,000 | -527% | 25 Sep 2021 | 31 Dec 2021 | 10-Q | 02 Feb 2023 | 2023 | Q1 | |
| Q4 2020 | $39,446,000 | +$91,884,000 | 26 Sep 2020 | 25 Dec 2020 | 10-Q | 04 Feb 2022 | 2022 | Q1 | ||
| Q4 2019 | $52,438,000 | 28 Sep 2019 | 27 Dec 2019 | 10-Q | 29 Jan 2021 | 2021 | Q1 |
Dolby Laboratories, Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $215,609,000 | +$455,823,000 | 28 Sep 2024 | 26 Sep 2025 | 10-K | 18 Nov 2025 | 2025 | FY | |
| 2024 | $240,214,000 | -$429,809,000 | -227% | 30 Sep 2023 | 27 Sep 2024 | 10-K | 18 Nov 2025 | 2025 | FY |
| 2023 | $189,595,000 | +$794,256,000 | 01 Oct 2022 | 29 Sep 2023 | 10-K | 18 Nov 2025 | 2025 | FY | |
| 2022 | $604,661,000 | -$757,714,000 | -495% | 25 Sep 2021 | 30 Sep 2022 | 10-K | 19 Nov 2024 | 2024 | FY |
| 2021 | $153,053,000 | -$121,333,000 | -44% | 26 Sep 2020 | 24 Sep 2021 | 10-K | 17 Nov 2023 | 2023 | FY |
| 2020 | $274,386,000 | +$394,043,000 | 28 Sep 2019 | 25 Sep 2020 | 10-K | 18 Nov 2022 | 2022 | FY | |
| 2019 | $119,657,000 | -$410,539,000 | -141% | 29 Sep 2018 | 27 Sep 2019 | 10-K | 17 Nov 2021 | 2021 | FY |
| 2018 | $290,882,000 | 30 Sep 2017 | 28 Sep 2018 | 10-K | 16 Nov 2020 | 2020 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.